Nevada Surgery and Cancer Care now offers genetic testing for ovarian, breast and colorectal cancers. Genetic testing determines any changes in the genes, chromosomes or proteins, which can then determine a person’s risk of developing a genetic disease.
Breast and Ovarian Genetic Testing:
A woman is at risk of breast and/or ovarian cancer if a harmful mutation is found on the BRCA1 and BRCA2 genes. Men may also have an increased risk of breast cancer with harmful genetic mutations of these genes as well. The BRCA1 and BRCA2 genes create proteins that suppress tumors they also help repair damaged DNA. When these genes are damaged they either do not create this protein at all or create a protein that does not function properly and damaged DNA cannot be repaired. This means that cells are more likely to develop mutations, which can lead to an increased cancer risk.
Current estimates project that 55 to 65 percent of women who inherit a harmful BRCA1 gene will develop breast cancer, where 45 percent of women who inherit a harmful BRCA2 gene will develop breast cancer.
39 percent of women who inherit a harmful BRCA1 gene will develop ovarian cancer and 11 to 17 percent of women who inherit a harmful BRCA2 gene will develop ovarian cancer.
To see if you should consider genetic testing for ovarian, breast or colorectal cancers, please take a look at our website and please call the Nevada Surgery and Cancer Care office if you have any questions regarding breast and ovarian genetic testing at 702-739-6467.